VCP-Eribulin is a drug-linker conjugate composed of VCP (ADC linker) and Eribulin (a tubulin inhibitor and a warhead in ADC). Eribulin (E-7389) is highly potent mitotic/microtubule inhibitor or microtubule targeting agent (MTA) used in the treatment of metastatic breast cancer. VCP-Eribulin is used in the synthesis of antibody drug conjugates-ADC.

纯度：≥98%

CAS：2130869-17-7